Eung-gyu S. Kim
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Impact of Low-Density Lipoprotein Cholesterol Levels on Atherosclerotic Vascular Changes: Analysis of Korean Treat Stroke to Target Trial.
Journal: Journal of stroke
Published: November 10, 2025
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial.
Journal: European stroke journal
Published: August 29, 2025
Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study.
Journal: Lipids in health and disease
Published: August 17, 2025
Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial.
Journal: Contemporary clinical trials
Published: June 17, 2025
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial.
Journal: European stroke journal
Published: February 15, 2025
Low-Density Lipoprotein Cholesterol Level, the Lower the Better? Analysis of Korean Patients in the Treat Stroke to Target Trial.
Journal: Journal of stroke
Published: January 23, 2025
Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: February 07, 2023
Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
Journal: Contemporary clinical trials
Published: October 24, 2022
Last Updated: 09/26/2026